Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Immunology

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.176.3.1600PMID 16424189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Pathogenesis of respiratory syncytial virus infection].

  2006cited by this paper
• Respiratory syncytial virus infection in elderly and high-risk adults.

  2005cited by this paper
• Respiratory Syncytial Virus Pneumonitis in Immunocompromised Adults: Clinical Features and Outcome

  2005cited by this paper
• Immunopathological mechanisms in respiratory syncytial virus disease

  2004cited by this paper
• Pathogenesis of Respiratory Syncytial Virus Infection

  2004cited by this paper
• The burden and impact of COPD in Asia and Africa.

  2004cited by this paper
• Respiratory syncytial virus: The virus, the disease and the immune response

  2004cited by this paper
• Improved Effector Activity and Memory CD8 T Cell Development by IL-2 Expression during Experimental Respiratory Syncytial Virus Infection 1

  2004cited by this paper
• Trafficking of natural killer cells.

  2004cited by this paper
• C and CX3C chemokines: cell sources and physiopathological implications.

  2004cited by this paper
• Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P

  2003cited by this paper
• Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression

  2002influential reference
• RSV-induced immunopathology: dynamic interplay between the virus and host immune response.

  2002cited by this paper
• Respiratory syncytial virus immunobiology and pathogenesis.

  2002cited by this paper
• Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract

  2002cited by this paper
• Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

  2001cited by this paper
• Unique Subpopulations of CD56+ NK and NK-T Peripheral Blood Lymphocytes Identified by Chemokine Receptor Expression Repertoire1

  2001cited by this paper
• Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence.

  2001cited by this paper
• The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.

  2001cited by this paper
• CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

  2001cited by this paper
• Interferon-γ stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence

  2001cited by this paper
• Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

  2000cited by this paper
• Interferon-γ Stimulates the Expression of CX3CL1/Fractalkine in Cultured Human Endothelial Cells

  2000cited by this paper
• Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells.

  2000cited by this paper
• Immune-mediated disease pathogenesis in respiratory syncytial virus infection.

  2000cited by this paper
• Fractalkine-Mediated Endothelial Cell Injury by NK Cells1

  2000cited by this paper
• The Attachment (G) Glycoprotein of Respiratory Syncytial Virus Contains a Single Immunodominant Epitope That Elicits Both Th1 and Th2 CD4+ T Cell Responses1

  2000cited by this paper
• A Role for Fractalkine and Its Receptor (CX3CR1) in Cardiac Allograft Rejection1

  2000cited by this paper
• Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse

  2000cited by this paper
• Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction

  1999cited by this paper
• Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G

  1999cited by this paper
• Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism

  1999cited by this paper
• Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication.

  1999cited by this paper
• Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice

  1999cited by this paper
• Atypical Pulmonary Eosinophilia Is Mediated by a Specific Amino Acid Sequence of the Attachment (G) Protein of Respiratory Syncytial Virus

  1998cited by this paper
• Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

  1998cited by this paper
• Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection

  1997cited by this paper
• Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

  1997cited by this paper
• New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road.

  1997cited by this paper
• CD8+ T cells control Th2‐driven pathology during pulmonary respiratory syncytial virus infection

  1997cited by this paper
• Heparin-dependent attachment ofrespiratory syncytial virus (RSV) to host cells

  1997cited by this paper
• Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion

  1997cited by this paper
• Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection

  1997cited by this paper
• Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus

  1995cited by this paper
• Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations).

  1994cited by this paper
• Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells

  1993cited by this paper
• Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies

  1992influential reference
• Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

  1991cited by this paper
• CD8+ alpha/beta or gamma/delta T cell receptor-bearing T cells from athymic nude mice are cytolytically active in vivo.

  1991cited by this paper
• Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins

  1990cited by this paper
• The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection

  1990cited by this paper
• Respiratory syncytial virus infection in human immunodeficiency virus-infected children.

  1990cited by this paper
• Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

  1988cited by this paper
• Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity.

  1980cited by this paper

• RSV vaccine development: advances and fusion protein-focused strategies

  2026cites this paper
• Advances in development of antiviral strategies against respiratory syncytial virus

  2025cites this paper
• Layer-by-Layer Microparticle Vaccines Containing a S177Q Point Mutation in the Central Conserved Domain of the RSV G Protein Improves Immunogenicity

  2025cites this paper
• Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals

  2025cites this paper
• Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus

  2024cites this paper
• The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis

  2024cites this paper
• KD-409, a Respiratory Syncytial Virus FG Chimeric Protein without the CX3C Chemokine Motif, Is an Efficient Respiratory Syncytial Virus Vaccine Preparation for Passive and Active Immunization in Mice

  2024cites this paper
• The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response

  2024cites this paper
• Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

  2023cites this paper
• Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response

  2023cites this paper
• Exploring different virulent proteins of human respiratory syncytial virus for designing a novel epitope-based polyvalent vaccine: Immunoinformatics and molecular dynamics approaches

  2022cites this paper
• RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses

  2022cites this paper
• Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge

  2022cites this paper
• RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein

  2022cites this paper
• Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children

  2022cites this paper
• Codon-optimization of the respiratory syncytial virus (RSV) G protein expressed in a vesicular stomatitis virus (VSV) vector improves immune responses in a cotton rat model.

  2022cites this paper
• Controlled Human Infection Models To Accelerate Vaccine Development

  2022cites this paper
• Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

  2022cites this paper
• Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus

  2022cites this paper
• Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)

  2021cites this paper
• Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats

  2021cites this paper
• Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies

  2021influential citation
• Structural Characterization and Binding Studies of the Ectodomain G Protein of Respiratory Syncytial Virus Reveal the Crucial Role of pH with Possible Implications in Host–Pathogen Interactions

  2021cites this paper
• Functional Features of the Respiratory Syncytial Virus G Protein

  2021cites this paper
• Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells

  2021cites this paper
• Immunopathology of RSV: An Updated Review

  2021cites this paper
• Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies.

  2020cites this paper
• Emerging small and large molecule therapeutics for respiratory syncytial virus

  2020cites this paper
• Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection

  2020cites this paper
• Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics

  2020cites this paper
• Pharmacological management of human respiratory syncytial virus infection

  2020cites this paper
• Investigation of 3D Primary Human Airway Cell Culture as a Viable and Successful Model for Study of Respiratory Syncytial Virus Infection and Antiviral Drug Treatment.

  2020cites this paper
• Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development

  2019cites this paper
• Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes

  2019cites this paper
• Respiratory syncytial virus reduces STAT3 phosphorylation in human memory CD8 T cells stimulated with IL-21

  2019cites this paper
• Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein

  2019cites this paper
• Respiratory syncytial virus (RSV): a scourge from infancy to old age

  2019cites this paper
• Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

  2019cites this paper
• Biophysical and flavonoid-binding studies of the G protein ectodomain of group A human respiratory syncytial virus

  2019cites this paper
• Respiratory syncytial virus activates Rab5a to suppress IRF1-dependent IFN-λ production, subverting the antiviral defense of airway epithelial cells

  2019cites this paper
• Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field

  2018cites this paper
• Patterns of antibody response during natural hRSV infection: insights for the development of new antibody-based therapies

  2018cites this paper
• Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies

  2018cites this paper
• Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection

  2018cites this paper
• The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection

  2017cites this paper
• Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus

  2017cites this paper
• Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases

  2017cites this paper
• Respiratory syncytial virus–Host interaction in the pathogenesis of bronchiolitis and its impact on respiratory morbidity in later life

  2017cites this paper
• Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection

  2017cites this paper
• Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity

  2017cites this paper
• Modulation of the host immune response by respiratory syncytial virus proteins

  2017cites this paper
• On viral infections in lung transplant recipients

  2017cites this paper
• Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection.

  2017cites this paper
• Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

  2017cites this paper
• A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

  2016cites this paper
• Human Respiratory Syncytial Virus: Infection and Pathology

  2016cites this paper
• Human Respiratory Syncytial Virus: An Introduction.

  2016cites this paper
• Recent advances in the development of subunit-based RSV vaccines

  2016cites this paper
• Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus

  2016cites this paper
• An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.

  2015cites this paper
• CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

  2015influential citation
• Respiratory Virus Vaccines

  2015cites this paper
• Immunology of bovine respiratory syncytial virus in calves.

  2015cites this paper
• Benzimidazole analogs inhibit respiratory syncytial virus G protein function

  2015cites this paper
• El virus sincitial respiratorio humano: una panorámica

  2015cites this paper
• Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease

  2015cites this paper
• 160 – Respiratory Syncytial Virus (RSV)

  2015cites this paper
• Modulation of host adaptive immunity by hRSV proteins

  2014cites this paper
• Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus

  2014cites this paper
• CD8+ T cell immunity against human respiratory syncytial virus.

  2014cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cites this paper
• Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.

  2014cites this paper
• An omics insight: A hope for HRSV vaccine

  2014cites this paper
• Regulatory immune cytokines in RSV infection

  2014cites this paper
• Central nervous system alterations caused by infection with the human respiratory syncytial virus

  2014cites this paper
• Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease

  2013influential citation
• Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses

  2013cites this paper
• Respiratory syncytial virus vaccine development.

  2013cites this paper
• Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis

  2013cites this paper
• Live-attenuated respiratory syncytial virus vaccines.

  2013cites this paper
• The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors

  2013cites this paper
• RSV Fusion: Time for a New Model

  2013cites this paper
• Subunit Vaccine Candidates Engineered from the Central Conserved Region of the RSV G Protein Aimed for Parenteral or Mucosal Delivery

  2013cites this paper
• in NK cytoskeleton organization and activation Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1

  2013cites this paper
• Advances in and the potential of vaccines for respiratory syncytial virus

  2013cites this paper
• Респираторно-синцитиальная вирусная инфекция. Особенности патогенеза, стратегия профилактики и лечения

  2013cites this paper
• A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

  2013cites this paper
• Understanding respiratory syncytial virus infection to improve treatment and immunity.

  2013cites this paper
• The adaptive immune response to respiratory syncytial virus.

  2013cites this paper
• Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains

  2012influential citation
• Dissecting the Role of 4-1BB and its Ligand in Enhancing CD8 Effector and Memory T Cell Responses

  2012cites this paper
• Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

  2012cites this paper
• Membrane-anchored chemokine fusion proteins as adjuvants for tumor therapy

  2012cites this paper
• Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice

  2012cites this paper
• Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

  2012cites this paper
• Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication

  2012cites this paper
• Mechanisms of resistance for human respiratory syncytial virus isolates against anti-fusion agents in tissue culture

  2012cites this paper
• Cutting Edge: Protective Effect of CX3CR1+ Dendritic Cells in a Vaccinia Virus Pulmonary Infection Model

  2012cites this paper
• Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant

  2012influential citation
• Respiratory syncytial virus infection and immunity

  2012cites this paper